[HTML][HTML] Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients

A Alzamzamy, H Elsayed, M Abd Elraouf… - World Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Hepatocellular carcinoma (HCC) accounts for 8.2% of all cancer-related
deaths worldwide. Being a vascular tumor, vascular endothelial growth factor (VEGF) plays …

Serological tumor markers of hepatocellular carcinoma: a meta-analysis

TD Hussein - The International journal of biological markers, 2015 - journals.sagepub.com
Background The clinical value of serum α-fetoprotein (AFP) to detect hepatocellular
carcinoma (HCC) has been questioned due to its low sensitivity and specificity. Other than …

[PDF][PDF] WJGO

ZM Chen, MS Peng, LS Wang, ZL Xu, MS Zeeshan… - 2023 - researchgate.net
BACKGROUND The distal-less homeobox (DLX) gene family plays an important role in the
development of several tumors. However, the expression pattern, prognostic and diagnostic …

[PDF][PDF] WJGO

A Alzamzamy, H Elsayed, M Abd Elraouf, H Eltoukhy… - 2021 - researchgate.net
Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis
C virus-related cirrhotic p Page 1 WJGO https://www.wjgnet.com 0 June 15, 2021 Volume 13 Issue 6 …